Ingenito Gary's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Sep 16, 2022
- Accession no.
- 0001161697-22-000468
- Filed
- Sep 16, 2022
- Trade date
- Sep 14, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.24M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ingenito GaryCIK 0001279473 | Officer (Chief Medical & Reg. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +55,000 | $4.01 | +$220,550 | 77,053 | Direct | |
| Sep 14, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −55,000 | $15.65F2 | −$860,750 | 22,053 | Direct | |
| Sep 14, 2022 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +88,000 | $4.64 | +$408,320 | 110,053 | Direct | |
| Sep 14, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −88,000 | $15.69F3 | −$1,380,720 | 22,053 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 | Common Stock | MOption exerciseDisposed | −55,000 | $0.00 | $0 | 1,016,667 | Direct | |
| Sep 14, 2022 | Common Stock | MOption exerciseDisposed | −88,000 | $0.00 | $0 | 928,667 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.56 to $15.80 per share.
Referenced by the price of 1 transaction in Table I.
- F3
Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.62 to $15.79 per share.
Referenced by the price of 1 transaction in Table I.